Pancreatic Cancer Research

ResearcherUniversity of ToyamaActive in the last 2 years

Naoki Toyooka

Matched on ORCID iD 0000-0002-9568-1528; OpenAlex author ID A5006686399. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
14
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: 2 papers · 2023: 2 papers · 2024: 1 paper

Papers 9

  1. Targeting Pancreatic Cancer with Novel Nicolaioidesin C Derivatives: Molecular Mechanism, In Vitro, and In Vivo Evaluations. Co-author DOI 10.1021/acs.jmedchem.4c01141↗
  2. Targeting Pancreatic Cancer with Novel Plumbagin Derivatives: Design, Synthesis, Molecular Mechanism, In Vitro and In Vivo Evaluation. Last author DOI 10.1021/acs.jmedchem.3c00394↗
  3. Nicolaioidesin C: An Antiausterity Agent Shows Promising Antitumor Activity in a Pancreatic Cancer Xenograft Mouse Model. Co-author DOI 10.1021/acs.jnatprod.3c00019↗
  4. Design and synthesis of novel pipernonaline derivatives as anti-austerity agents against human pancreatic cancer PANC-1 cells. Last author DOI 10.1016/j.bmc.2022.116963↗
  5. Abietane diterpenes from Abies spectabilis and their anti-pancreatic cancer activity against the MIA PaCa-2 cell line. Co-author DOI 10.1016/j.bmcl.2022.128723↗
  6. Anti-Austerity Activity of Thai Medicinal Plants: Chemical Constituents and Anti-Pancreatic Cancer Activities of Kaempferia parviflora. Co-author DOI 10.3390/plants10020229↗
  7. Chemical constituents of Callistemon citrinus from Egypt and their antiausterity activity against PANC-1 human pancreatic cancer cell line. Co-author DOI 10.1016/j.bmcl.2020.127352↗
  8. Highly Potent Antiausterity Agents from Callistemon citrinus and Their Mechanism of Action against the PANC-1 Human Pancreatic Cancer Cell Line. Co-author DOI 10.1021/acs.jnatprod.0c00330↗
  9. Synthesis of new tricyclic thiolactams as potent antitumor agent for pancreatic cancer. Last author DOI 10.1016/j.bmcl.2016.04.035↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Suresh Awale · 8 shared papers, 2020–2024 · strength 1.22
  2. Takuya Okada · 6 shared papers, 2016–2024 · strength 0.89
  3. Nguyễn Duy Phan · 5 shared papers, 2022–2024 · strength 0.86
  4. Tsutomu Fujii · 4 shared papers, 2022–2024 · strength 0.70
  5. Ashraf M. Omar · 5 shared papers, 2020–2023 · strength 0.69
  6. Juthamart Maneenet · 4 shared papers, 2022–2024 · strength 0.68
  7. Sijia Sun · 4 shared papers, 2020–2022 · strength 0.52
  8. Dya Fita Dibwe · 4 shared papers, 2020–2022 · strength 0.52
  9. Ahmed M. Tawila · 2 shared papers, 2020 · strength 0.24
  10. Takeyoshi Yamazaki · 1 shared paper, 2024 · strength 0.21
  11. Johji Imura · 1 shared paper, 2023 · strength 0.18
  12. Mitsuro Kanda · 1 shared paper, 2023 · strength 0.16
  13. Yuki Fujihashi · 1 shared paper, 2022 · strength 0.16
  14. Hiroyasu Esumi · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.